Special Products Limited, the specialty pharmaceutical company focused on niche therapeutic areas, is pleased to announce that Andrew Tittershill, an experienced pharmacist, has been appointed as Director of Unlicensed Medicines.
Andrew, who joined Special Products Limited in February 2012, will also join the company’s Board of Directors. In the newly created position of Director of Unlicensed Medicines, Andrew will be responsible for focusing on how best to maximise the opportunities within our current portfolio, and the identification, development and introduction of new products to help support the continued growth of Special Products Limited.
Andrew has a wealth of experience within the Pharmaceutical Industry in portfolio development and commercial activities associated with licensed and unlicensed medicines. He has worked for some large, international pharmaceutical companies in the past and more recently with mid-sized companies such as Martindale Pharma and Waymade Healthcare.
Special Products’ Chairman, Graham March, commented: “I am delighted to welcome Andrew Tittershill to our Board of Directors in the newly created position of Director of Unlicensed Medicines. His breadth of experience in the pharmaceutical industry has been clearly evident since he joined Special Products Limited in 2012 and I look forward to his continued contribution to the company in this new role”.